Top Markets
#1 ADO Protocol ADO Protocol +328.68%
#2 GoPlus Security GoPlus Security +51.28%
#3 Nockchain Nockchain +41.03%
#4 Starpower Starpower +35.74%
#5 The Black Bull The Black Bull +35.04%
#6 Verus Coin Verus Coin +33.47%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +33.42%
#8 Tutorial Tutorial +32.05%
#9 GAIB AID GAIB AID +24.67%
#10 Moolah Moolah +21.60%
Coin of the day
ADO Protocol ADO Protocol
Setări
Limbă
ROMâNă
Monedă
USD
Temă
NuCana plc NuCana plc

NuCana plc

NCNA
Rang în acțiuni #32729
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
Preț acțiune
$1.56
Capitalizare de piață
$9.44M
Schimbare (1 zi)
-2.20%
Schimbare (1 an)
-58.31%
Țară
GB
Tranzacționează NuCana plc (NCNA)

Categorie

Healthcare
Istoricul spliturilor pentru NuCana plc (NCNA)
Acțiunea NuCana plc (simbol: NCNA) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 17, 2026.
O acțiune NCNA cumpărată înainte de Aug 17, 2026 este echivalentă astăzi cu 0 acțiuni NCNA.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE